cyclopentane has been researched along with Diabetic Angiopathies in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dechavanne, M; Desnoyers, P; Stoltz, JF; Vainer, H; Verry, M | 1 |
Riveline, B | 1 |
Leclercq-Meyer, V; Malaisse, WJ | 1 |
Masbernard, A; Portal, A | 1 |
Simonin, R | 1 |
Duhault, J; Lebon, F | 1 |
1 trial(s) available for cyclopentane and Diabetic Angiopathies
Article | Year |
---|---|
[Long term study of a new antidiabetic agent in 1183 cases].
Topics: Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Drug Evaluation; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds | 1974 |
5 other study(ies) available for cyclopentane and Diabetic Angiopathies
Article | Year |
---|---|
[Effect of gliclazide on platelet behavior].
Topics: Adenylyl Cyclases; Blood Glucose; Blood Platelets; Carbon Radioisotopes; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Humans; Hypoglycemic Agents; Platelet Adhesiveness; Pyrroles; Sulfonylurea Compounds; Tritium; Ultracentrifugation | 1974 |
Insulinotropic action of a new sulfonylurea: gliclazide.
Topics: Animals; Cyclopentanes; Diabetic Angiopathies; Dogs; Drug Interactions; Fatty Acids, Nonesterified; Glucose; Glyburide; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreas; Pyrroles; Rats; Sulfonylurea Compounds | 1972 |
[The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
Topics: Aged; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Microcirculation; Middle Aged; Pyrroles; Sex Factors; Sulfonylurea Compounds; Time Factors | 1972 |
[Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
Topics: Adult; Aged; Cyclopentanes; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pyrroles; Sulfonylurea Compounds | 1972 |
The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
Topics: Animals; Blood Coagulation Tests; Capillaries; Capillary Permeability; Cyclopentanes; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypoglycemic Agents; Male; Mesentery; Pyrroles; Rats; Skin; Sulfonylurea Compounds; Thrombosis | 1972 |